Omaha Drug Attorney Dan Stockmann: Feds Won’t Reclassify Marijuana this Year
Omaha drug attorney Daniel Stockmann, who focuses his practice on helping people accused of breaking marijuana laws, explores the DEA’s future ruling regarding the reclassification of marijuana. For a free legal consultation with the top-rated drug lawyer, visit NebraskaInterstateDrugDefense.com or call (855) 782-1735.
(firmenpresse) - Omaha drug attorney Daniel Stockmann says the federal government is not likely to reschedule marijuana in 2016. It€™s presently a Schedule I substance, though there has recently been a lot of talk about recategorizing it to a Schedule II substance.
For a free case evaluation with an experienced Omaha drug attorney, go to [NebraskaInterstateDrugDefense.com](http://www.nebraskainterstatedrugdefense.com/?utm_source=Press%20Cable&utm_medium=Press%20Release&utm_term=Omaha%20Drug%20Attorney&utm_content=Omaha%20Drug%20Attorney%20Dan%20Stockmann%3A%20Feds%20Won%E2%80%99t%20Reclassify%20Marijuana%20this%20Year&utm_campaign=Omaha%20Drug%20Attorney%20Dan%20Stockmann%3A%20Feds%20Won%E2%80%99t%20Reclassify%20Marijuana%20this%20Year) or call (855) 782-1735.
Reclassifying marijuana as a Schedule II substance would mean that the government recognizes that it has medicinal value, a topic that€™s been highly debated for decades. As a Schedule I substance, it sits beside LSD, heroin, and ecstasy in terms of classification. However, moving it to Schedule II, it will sit alongside Ritalin and Oxycodone; drugs that are widely used for their medical benefits, but also have the potential to be abused.
The FDA has examined the medical benefits of marijuana before. The agency uses a five-tiered rating system, that evaluates whether:
1. The chemistry of the compound is known and reproducible
2. €œAdequate€ safety studies have been conducted
3. Similar studies have proven the substance€™s efficacy
4. €œQualified experts€ accept the substance
5. Scientific evidence is widely available
In 2001 and again in 2006, the FDA recommended that marijuana remain a Schedule I substance based on this criteria. However, as many states have adopted new laws that permit cannabis, both for medicinally and recreationally, additional research has been carried out. The DEA recently asked the FDA to conduct another study and provide an opinion on reclassifying marijuana.
Call (855) 782-1735 or visit [NebraskaInterstateDrugDefense.com](http://www.nebraskainterstatedrugdefense.com/?utm_source=Press%20Cable&utm_medium=Press%20Release&utm_term=Omaha%20Drug%20Attorney&utm_content=Omaha%20Drug%20Attorney%20Dan%20Stockmann%3A%20Feds%20Won%E2%80%99t%20Reclassify%20Marijuana%20this%20Year&utm_campaign=Omaha%20Drug%20Attorney%20Dan%20Stockmann%3A%20Feds%20Won%E2%80%99t%20Reclassify%20Marijuana%20this%20Year) for a free consultation with Omaha drug attorney, Daniel Stockmann.
Initially, the DEA suggested it would announce whether marijuana would be federally reclassified during the first half of 2016. Then, representatives shifted the date and said they would make an official statement on or before August 1. However, the agency provided the Post with a written statement that explained the DEA was not bound to any particular timeframe and would release their findings after proper research was carried out. The statement also said that the FDA had provided them with their findings approximately one year ago, though the DEA did not hint at what the FDA€™s recommendation was. At this stage, experts believe that marijuana will be reclassified as a Schedule II substance, but that it will not happen during this calendar year.
About Nebraska Interstate Drug Defense
Nebraska Interstate Drug Defense is the website operated by Omaha criminal defense lawyer, Daniel Stockmann. Mr. Stockmann is a dedicated drug attorney who handles each case he takes on of its own merits, to ensure that the best possible defense is used. He utilizes various strategies, from citing constitutional rights violations to annihilating the state€™s evidence, so that his clients are protected and can resume their normal lives quickly. For more information on the practice or for a free case evaluation with Mr. Stockmann, go to [NebraskaInterstateDrugDefense.com](http://www.nebraskainterstatedrugdefense.com/?utm_source=Press%20Cable&utm_medium=Press%20Release&utm_term=Omaha%20Drug%20Attorney&utm_content=Omaha%20Drug%20Attorney%20Dan%20Stockmann%3A%20Feds%20Won%E2%80%99t%20Reclassify%20Marijuana%20this%20Year&utm_campaign=Omaha%20Drug%20Attorney%20Dan%20Stockmann%3A%20Feds%20Won%E2%80%99t%20Reclassify%20Marijuana%20this%20Year) or call (855) 782-1735 today.
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Nebraska Interstate Drug Defense
http://www.nebraskainterstatedrugdefense.com/
Nebraska Interstate Drug Defense
http://www.nebraskainterstatedrugdefense.com/
(844) 336-1367
N/A
Omaha
Untied States Of America
Datum: 20.09.2016 - 01:02 Uhr
Sprache: Deutsch
News-ID 495647
Anzahl Zeichen: 4738
contact information:
Contact person: Dan Stockmann
Town:
Omaha
Phone: (844) 336-1367
Kategorie:
Various
Typ of Press Release: Unternehmensinformation
type of sending: Veröffentlichung
Date of sending: 19/09/2016
Diese Pressemitteilung wurde bisher 733 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Omaha Drug Attorney Dan Stockmann: Feds Won’t Reclassify Marijuana this Year"
steht unter der journalistisch-redaktionellen Verantwortung von
Nebraska Interstate Drug Defense (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
